Valuation: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Market Cap 24.92B 3.69B 3.2B 2.99B 2.73B 5.15B 352B 5.23B 35.05B 13.75B 176B 13.87B 13.57B 587B P/E 2024
10.7x
P/E 2025 16.5x
Enterprise Value 20.67B 3.06B 2.65B 2.48B 2.27B 4.27B 292B 4.34B 29.07B 11.41B 146B 11.5B 11.25B 487B EV / Sales 2024
2.3x
EV / Sales 2025 5.39x
Free-Float
31.71%
Yield 2024
4.16%
Yield 2025 10.5%
1 day+0.08%
1 week-1.69%
Current month-2.82%
1 month+0.43%
3 months-11.91%
6 months-20.24%
Current year-18.43%
1 week 36.51
Extreme 36.51
37.86
1 month 36.1
Extreme 36.1
39.45
Current year 34.7
Extreme 34.7
48.2
1 year 34.7
Extreme 34.7
50.97
3 years 23.4
Extreme 23.4
50.97
5 years 17.98
Extreme 17.98
56.26
10 years 11.8
Extreme 11.8
56.26
Manager TitleAgeSince
Director of Finance/CFO 48 2023-07-20
Chief Tech/Sci/R&D Officer 56 2017-10-09
Investor Relations Contact - -
Director TitleAgeSince
Chairman 55 2024-11-25
Director/Board Member 56 2012-11-30
Director/Board Member 55 2021-12-09
Date Insider Type Main position Quantity % Market Cap.
1/8/20 Buy

Company Secretary

30,000 0.0053%
1/8/20 Buy

Chief Technology Officer

70,000 0.0124%
1/8/20 Buy 70,000 0.0124%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%-1.69%-6.84%-4.86% 3.69B
+0.85%-2.10%-8.41%-6.23% 13.54B
+1.24%-2.42%+5.79%+3.21% 5.11B
+0.40%-3.72%-30.92%-55.78% 5.11B
-0.59%+1.02%+5.69%-29.71% 4.18B
-0.04%-3.58%-2.15%+4.52% 3.54B
-0.57%-1.70%-3.04%+15.95% 3.46B
-0.50%-0.56%-12.42%-15.41% 2.48B
+0.67%-3.03%-3.07%+43.25% 1.87B
-0.71%-1.19%-28.42%-11.77% 1.75B
Average +0.08%-1.02%-8.38%-5.68% 4.47B
Weighted average by Cap. +0.32%-1.08%-7.78%-8.99%

Financials

2024 2025
Net sales 7.31B 1.08B 938M 876M 801M 1.51B 103B 1.53B 10.28B 4.03B 51.67B 4.07B 3.98B 172B 4.92B 729M 631M 590M 539M 1.02B 69.51B 1.03B 6.92B 2.71B 34.77B 2.74B 2.68B 116B
Net income 2.23B 330M 286M 267M 244M 460M 31.51B 468M 3.14B 1.23B 15.77B 1.24B 1.21B 52.51B 2.13B 316M 273M 256M 234M 440M 30.12B 447M 3B 1.18B 15.07B 1.19B 1.16B 50.19B
Net Debt -3.91B -579M -501M -468M -428M -807M -55.21B -819M -5.49B -2.16B -27.62B -2.17B -2.13B -92B -4.26B -631M -546M -511M -467M -879M -60.17B -893M -5.99B -2.35B -30.1B -2.37B -2.32B -100B
Logo Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
3,890
Date Price Change Volume
26-08-10 CN¥37.21 +0.08% 3,606,621
26-08-07 CN¥37.18 +0.84% 3,094,398
26-08-06 CN¥36.87 -1.15% 3,901,130
26-08-05 CN¥37.30 -1.35% 3,319,450
26-08-04 CN¥37.81 -0.11% 2,440,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600329 Stock